Kaposi's sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and more

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• The complement system is crucial for innate immunity and adaptive immune responses.
• Pathogens employ complement evasion strategies, highlighting the need to understand these mechanisms.
• Kaposi's sarcoma-associated herpesvirus (KSHV) utilizes complement inhibitors like KCP.

Purpose of the Study:

• To review structure-function studies of KCP, a membrane-bound complement inhibitor from KSHV.
• To elucidate the molecular mechanisms of KCP-mediated complement inhibition.
• To understand KCP's role in KSHV virion binding and infection.

Main Methods:

• Review of structure-function studies.
• Molecular modeling.
• Site-directed mutagenesis.
• Analysis of KCP's interaction with complement factors C3b and C4b.
• Investigation of KCP's binding to heparin/heparan sulfate.

Main Results:

• KCP accelerates the decay of the classical C3 convertase.
• KCP induces the degradation of C4b and C3b via factor I.
• Specific surface sites on KCP are essential for complement inhibition.
• KCP's structure mimics endogenous human complement inhibitors.
• KCP possesses a heparin/heparan sulfate-binding site that enhances virion-cell attachment.

Conclusions:

• KCP is a potent KSHV-encoded complement inhibitor that functions by mimicking host regulators.
• KCP's dual role in immune evasion and enhancing viral entry is critical for KSHV pathogenesis.
• Understanding KCP's structure-function relationship can inform therapeutic strategies against KSHV infections.